Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: A population-based cross-sectional study

202186 citationsJournal Articlegold Open Access

Authors

Manoj Murhekar · National Institute of Epidemiology

Tarun Bhatnagar · National Institute of Epidemiology

Jeromie Wesley Vivian Thangaraj · National Institute of Epidemiology

V. Saravanakumar · National Institute of Epidemiology

Muthusamy Santhosh Kumar · Software Training and Development Centre

Sriram Selvaraju · National Institute of Research in Tuberculosis

Kiran Rade

Abstract

Nearly two-thirds of individuals aged ≥6 years from the general population and 85% of HCWs had antibodies against SARS-CoV-2 by June-July 2021 in India. As one-third of the population is still seronegative, it is necessary to accelerate the coverage of COVID-19 vaccination among adults and continue adherence to non-pharmaceutical interventions.

Topics & Keywords

SARS-CoV-2 and COVID-19 Research COVID-19 Clinical Research Studies Vaccine Coverage and Hesitancy

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: PLoS Medicine

Volume 18, Issue 12, pp. e1003877-e1003877

DOI: 10.1371/journal.pmed.1003877

Field-Weighted Citation Impact: 4.94